Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Dermatological Research
Published in: Archives of Dermatological Research 3/2022

01-04-2022 | Acne Inversa | Original Paper

Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients

Authors: Paul C. Macklis, Kelly Tyler, Jessica Kaffenberger, Shawn Kwatra, Benjamin H. Kaffenberger

Published in: Archives of Dermatological Research | Issue 3/2022

Login to get access

Abstract

Background

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that substantially reduces patient quality of life. Many HS patients ask their dermatologist about potential lifestyle modifications, such as following particular diets or avoiding specific products, in an attempt to alleviate their symptoms. However, insufficient research has been conducted to support well-informed lifestyle modification counseling, and patients frequently defer to anecdotal endorsements of various interventions found on social media support groups. Therefore, we sought to clarify what lifestyle modifications were capable of improving HS symptoms.

Methods

We conducted a survey-based study to examine modifiable risk factors and their association with the severity of HS. Five hundred and ninety-one patients with HS participated in an online survey detailing the severity of their HS symptoms before and after various lifestyle interventions. Average improvements in both subjective and objective ratings of symptom severity were calculated and statistical differences between the levels of improvement seen among various categories of lifestyle interventions were determined.

Results

Numerous lifestyle interventions including substantial weight loss, smoking cessation, use of gentle skin and depilatory products, and menstrual regulation were associated with both subjective and objective improvements in symptom severity.

Conclusions

Our results suggest that patients affected by HS may experience clinically significant improvement from a variety of lifestyle modifications.
Literature
1.
Cosmatos I, Matcho A, Weinstein R, Montgomery MO, Stang P (2013) Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol 68(3):412–419CrossRef
2.
Ofenloch RF (2017) Health-related quality of life in hidradenitis suppurativa. Br J Dermatol 176(4):861–862CrossRef
3.
Danby FW (2015) Diet in the prevention of hidradenitis suppurativa (acne inversa). J Am Acad Dermatol 73(5 Suppl 1):S52-54CrossRef
4.
Ingram JR, Collier F, Brown D, Burton T, Burton J, Chin MF et al (2019) British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018. Br J Dermatol 180(5):1009–1017CrossRef
5.
Eiken HC, Holm JG, Thomsen SF (2020) Studies on the role of diet in the management of hidradenitis suppurativa are needed. J Am Acad Dermatol 82(4):e137–e138CrossRef
6.
Dempsey A, Butt M, Kirby JS (2020) Prevalence and Impact of Dietary Avoidance among Individuals with hidradenitis suppurativa. DRM 236(4):289–295
7.
von der Werth JM, Williams HC (2000) The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 14(5):389–392CrossRef
8.
Alikhan A, Lynch PJ, Eisen DB (2009) Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 60(4):539–561CrossRef
9.
Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F et al (2008) Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 59(4):596–601CrossRef
10.
Sartorius K, Emtestam L, Jemec GBE, Lapins J (2009) Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 161(4):831–839CrossRef
11.
Joseph MA, Jayaseelan E, Ganapathi B, Stephen J (2005) Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat 16(2):75–78CrossRef
12.
Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD (2013) Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County. Minnesota J Invest Dermatol 133(1):97–103CrossRef
13.
Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F et al (2009) Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 61(1):51–57CrossRef
14.
Crowley J, Mekkes J, Zouboulis C, Scheinfeld N, Kimball A, Sundaram M et al (2014) Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. Br J Dermatol 171(6):1561–1565CrossRef
15.
Schrader AMR, Deckers IE, van der Zee HH, Boer J, Prens EP (2014) Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol 71(3):460–467CrossRef
16.
Shalom G, Freud T, Harman-Boehm I, Polishchuk I, Cohen AD (2015) Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients. Br J Dermatol 173(2):464–470CrossRef
17.
Bettoli V, Naldi L, Cazzaniga S, Zauli S, Atzori L, Borghi A et al (2016) Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry. Br J Dermatol 174(1):195–197CrossRef
18.
Egeberg A, Gislason GH, Hansen PR (2016) Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa. JAMA Dermatol 152(4):429–434CrossRef
19.
Vossen ARJV, van Straalen KR, Prens EP, van der Zee HH (2017) Menses and pregnancy affect symptoms in hidradenitis suppurativa: a cross-sectional study. J Am Acad Dermatol 76(1):155–156CrossRef
20.
Barth JH, Layton AM, Cunliffe WJ (1996) Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 134(6):1057–1059CrossRef
21.
22.
23.
Senthilnathan A, Kolli SS, Cardwell LA, Richardson I, Feldman SR, Pichardo RO (2019) Validation of a hidradenitis suppurativa self-assessment tool. J Cutan Med Surg 23(4):388–390CrossRef
24.
25.
Tavora IG, Bissoli GC, Miot HA, Schmitt JV (2019) Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group. An Bras Dermatol 94(3):298–303CrossRef
26.
27.
28.
Macklis P, Adams KM, Li D, Krispinsky A, Bechtel M, Trinidad J, et al. (2019) The impacts of oral health symptoms, hygiene, and diet on the development and severity of psoriasis. Dermatol Online J. 25(7):1–5
29.
Prens E, Deckers I (2015) Pathophysiology of hidradenitis suppurativa: an update. J Am Acad Dermatol 73(5):S8-11CrossRef
30.
David Boothe W, Tarbox JA, Tarbox MB (2017) Atopic dermatitis: pathophysiology. Adv Exp Med Biol 1027:21–37CrossRef
31.
American College of Physicians (2003) Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 138(11):891CrossRef
32.
Metadata
Title
Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients
Authors
Paul C. Macklis
Kelly Tyler
Jessica Kaffenberger
Shawn Kwatra
Benjamin H. Kaffenberger
Publication date
01-04-2022
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 3/2022
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-021-02233-y

Other articles of this Issue 3/2022

Archives of Dermatological Research 3/2022 Go to the issue

Original Paper

HLA-G, cytokines, and cytokine receptors in the non-aggressive basal cell carcinoma microenvironment

Review

Patient-reported outcome measures for patients with nail conditions: a systematic review of the psychometric evidence

Review

Home-based devices in dermatology: a systematic review of safety and efficacy

Original Paper

Risk factors and patterns of recurrence after sentinel lymph node biopsy for thin melanoma

Original Paper

Secular trends of atopic dermatitis and its comorbidities in United States children between 1997 and 2018

Concise Communication

Treatment strategies for hidradenitis suppurativa: real-life data from a tertiary Greek hospital